company background image
4737

Bionime TWSE:4737 Stock Report

Last Price

NT$77.20

Market Cap

NT$4.7b

7D

0%

1Y

11.6%

Updated

25 Jan, 2023

Data

Company Financials +

4737 Stock Overview

Bionime Corporation designs, manufactures, and sells medical instruments in China, Switzerland, the United States, Algeria, Egypt, and internationally.

4737 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth1/6
Past Performance1/6
Financial Health2/6
Dividends1/6

My Notes

New

Notes are coming soon

Bionime Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Bionime
Historical stock prices
Current Share PriceNT$77.20
52 Week HighNT$97.80
52 Week LowNT$67.00
Beta0.70
1 Month Change-0.26%
3 Month Change5.03%
1 Year Change11.56%
3 Year Change-11.87%
5 Year Change43.49%
Change since IPO14.76%

Recent News & Updates

Recent updates

These Return Metrics Don't Make Bionime (TPE:4737) Look Too Strong

Apr 29
These Return Metrics Don't Make Bionime (TPE:4737) Look Too Strong

Looking For Steady Income For Your Dividend Portfolio? Is Bionime Corporation (TPE:4737) A Good Fit?

Mar 23
Looking For Steady Income For Your Dividend Portfolio? Is Bionime Corporation (TPE:4737) A Good Fit?

Did You Participate In Any Of Bionime's (TPE:4737) Respectable 83% Return?

Mar 05
Did You Participate In Any Of Bionime's (TPE:4737) Respectable 83% Return?

Should You Use Bionime's (TPE:4737) Statutory Earnings To Analyse It?

Feb 15
Should You Use Bionime's (TPE:4737) Statutory Earnings To Analyse It?

Bionime (TPE:4737) Has A Somewhat Strained Balance Sheet

Feb 01
Bionime (TPE:4737) Has A Somewhat Strained Balance Sheet

How Has Bionime (TPE:4737) Allocated Its Capital?

Jan 19
How Has Bionime (TPE:4737) Allocated Its Capital?

A Closer Look At Bionime Corporation's (TPE:4737) Uninspiring ROE

Jan 06
A Closer Look At Bionime Corporation's (TPE:4737) Uninspiring ROE

A Look At The Fair Value Of Bionime Corporation (TPE:4737)

Dec 22
A Look At The Fair Value Of Bionime Corporation (TPE:4737)

Bionime Corporation (TPE:4737) Investors Should Think About This Before Buying It For Its Dividend

Dec 09
Bionime Corporation (TPE:4737) Investors Should Think About This Before Buying It For Its Dividend

Bionime (TPE:4737) Has Compensated Shareholders With A Respectable 50% Return On Their Investment

Nov 24
Bionime (TPE:4737) Has Compensated Shareholders With A Respectable 50% Return On Their Investment

Shareholder Returns

4737TW Medical EquipmentTW Market
7D0%0%0.0004%
1Y11.6%3.9%-15.5%

Return vs Industry: 4737 exceeded the TW Medical Equipment industry which returned 3.3% over the past year.

Return vs Market: 4737 exceeded the TW Market which returned -15.6% over the past year.

Price Volatility

Is 4737's price volatile compared to industry and market?
4737 volatility
4737 Average Weekly Movement1.7%
Medical Equipment Industry Average Movement5.1%
Market Average Movement4.0%
10% most volatile stocks in TW Market7.2%
10% least volatile stocks in TW Market1.8%

Stable Share Price: 4737 is less volatile than 75% of TW stocks over the past 3 months, typically moving +/- 2% a week.

Volatility Over Time: 4737's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2003n/aRoy Huanghttps://www.bionime.com

Bionime Corporation designs, manufactures, and sells medical instruments in China, Switzerland, the United States, Algeria, Egypt, and internationally. The company offers blood glucose monitors, as well as accessories, such as test strips and lancing devices medical equipment companies, pharmacies, and hospitals. It is also involved in the provision of biotechnology services; examining of pharmaceuticals; and selling of precision instruments.

Bionime Corporation Fundamentals Summary

How do Bionime's earnings and revenue compare to its market cap?
4737 fundamental statistics
Market CapNT$4.69b
Earnings (TTM)NT$95.00m
Revenue (TTM)NT$2.09b

49.3x

P/E Ratio

2.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
4737 income statement (TTM)
RevenueNT$2.09b
Cost of RevenueNT$1.19b
Gross ProfitNT$897.25m
Other ExpensesNT$802.25m
EarningsNT$95.00m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)1.57
Gross Margin42.90%
Net Profit Margin4.54%
Debt/Equity Ratio113.1%

How did 4737 perform over the long term?

See historical performance and comparison

Dividends

2.6%

Current Dividend Yield

127%

Payout Ratio